Clinical consequences of iron overload in hemochromatosis homozygotes.
Ajioka
Richard S
RS
Division of Hematology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Kushner
James P
JP
D000328:Adult; D017677:Age Distribution; D000368:Aged; D019943:Amino Acid Substitution; D001782:Blood Donors; D002140:California / Q000453:epidemiology; D003062:Codon / Q000235:genetics; D005260:Female; D005293:Ferritins / Q000097:blood; D020022:Genetic Predisposition to Disease; D006432:Hemochromatosis / Q000150:complications* / Q000235:genetics / Q000628:therapy; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I / Q000235:genetics*; D006720:Homozygote; D006801:Humans; D007501:Iron / Q000097:blood; D019190:Iron Overload / Q000453:epidemiology / Q000209:etiology / Q000473:pathology*; D008297:Male; D008403:Mass Screening; D008565:Membrane Proteins / Q000235:genetics*; D008875:Middle Aged; D020125:Mutation, Missense; D009664:Norway / Q000453:epidemiology; D015588:Observer Variation; D019683:Penetrance; D018962:Phlebotomy; D017354:Point Mutation; D015983:Selection Bias; D014168:Transferrin / Q000032:analysis
D003062:Codon; C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D014168:Transferrin; D005293:Ferritins; D007501:Iron